Kane Biotech Inc.
KNBIF
$0.0643
-$0.002-3.02%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 403.00K | 737.90K | 610.50K | 567.30K | 1.20M |
Total Receivables | 582.50K | 320.30K | 83.60K | 78.10K | 633.90K |
Inventory | 509.50K | 531.70K | 179.30K | 189.60K | 558.50K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 142.70K | 122.00K | 2.00M | 1.98M | 212.70K |
Total Current Assets | 1.64M | 1.71M | 2.87M | 2.82M | 2.61M |
|
|||||
Total Current Assets | 1.64M | 1.71M | 2.87M | 2.82M | 2.61M |
Net Property, Plant & Equipment | 714.90K | 731.60K | 761.50K | 807.00K | 893.90K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 538.20K | 533.10K | 532.40K | 555.30K | 599.10K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 119.60K | 120.20K | 345.40K |
Total Assets | 2.89M | 2.98M | 4.28M | 4.30M | 4.44M |
|
|||||
Total Accounts Payable | 517.80K | 373.30K | 379.90K | 330.90K | 275.80K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 6.00K | 5.90K | 4.96M | 5.02M | 4.77M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 331.80K | 318.00K | 312.10K | 341.10K | 341.30K |
Total Finance Division Other Current Liabilities | 1.19M | 1.38M | 3.44M | 2.55M | 1.74M |
Total Other Current Liabilities | 1.19M | 1.38M | 3.44M | 2.55M | 1.74M |
Total Current Liabilities | 2.04M | 2.08M | 9.09M | 8.25M | 7.12M |
|
|||||
Total Current Liabilities | 2.04M | 2.08M | 9.09M | 8.25M | 7.12M |
Long-Term Debt | 776.30K | 830.20K | 901.60K | 986.20K | 1.03M |
Short-term Debt | 6.00K | 5.90K | 4.96M | 5.02M | 4.77M |
Capital Leases | 581.30K | 595.40K | 623.30K | 660.80K | 666.10K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 703.50K | 772.90K | 814.10K |
Total Liabilities | 3.40M | 3.50M | 11.32M | 10.67M | 9.63M |
|
|||||
Common Stock & APIC | 24.11M | 23.28M | 23.38M | 23.80M | 23.08M |
Retained Earnings | -24.67M | -23.91M | -32.15M | -31.90M | -29.98M |
Treasury Stock & Other | 48.70K | 102.70K | 103.80K | 106.50K | 102.50K |
Total Common Equity | -509.70K | -527.30K | -8.66M | -7.99M | -6.80M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -509.70K | -527.30K | -8.66M | -7.99M | -6.80M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | 1.62M | 1.63M | 1.61M |
Total Equity | -509.70K | -527.30K | -7.04M | -6.37M | -5.18M |
|